D-0392-2025 Class II Ongoing

Recalled by Nubratori, Inc — Torrance, CA

FDA drug recall D-0392-2025 was initiated by Nubratori, Inc on Apr 15, 2025 and is designated Class II. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are… The recall status is ongoing. Affected quantity: 20 boxes.

Recall details

Product Type
Drugs
Report Date
May 7, 2025
Initiation Date
Apr 15, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20 boxes

Product description

Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative Free, For Iontophoresis Use Only, Non-Sterile Product, Not for Injection, NUBRATORI RX, 381 Van Ness Ave# 1507, CA 90501, NDC 71300-6564-1 (box), 71300-6564-3 (vial).

Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.

Distribution pattern

PA and CA.

Code information

Lot #: C04292401X1, BUD: 12/25/2025 (box).

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0392-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0392-2025. Report a data issue: hello@regdatalab.com.